Clinical Trial Results:
            ICON7 - A randomised, two-arm, multicentre Gynaecologic Cancer InterGroup trial of adding bevacizumab to standard chemotherapy (carboplatin and paclitaxel) in patients with epithelial ovarian cancer. 
    
| 
                 Summary 
         | 
        |
    EudraCT number  | 
        2005-003929-22 | 
    Trial protocol  | 
        FR FI DE DK SE ES GB | 
    Global completion date  | 
        
                                    31 Mar 2013
                             
         | 
    
| 
                 Paediatric regulatory details 
         | 
        |
    Is the trial part of an agreed EMA paediatric investigation plan?  | 
        
                                        No
                                 
         | 
    
    Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?  | 
        
                                        No
                                 
         | 
    
    Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?  | 
        
                                        No
                                 
         | 
    
| 
                 Results information 
         | 
        |
    Results version number  | 
        v1(current) | 
    This version publication date  | 
        
                                    06 Jan 2017
                             
         | 
    
    First version publication date  | 
        
                                    06 Jan 2017
                             
         | 
    
    Other versions  | 
        |
    Summary report(s)  | 
                                ICON7 PFS NEJM ICON7 NEJM Suppl Appendix ICON7 NEJM Protocol ICON7 OS Lancet Onc  | 
    
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.